BTSG

BrightSpring Health Services, Inc. Common Stock

Fundamental data last updated:October 12, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Healthcare Information Services

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

Pending Announcement

Business Summary

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.

 


Analyze BTSG on TradingView

VALUATION

P/E

53.10

Market Cap ($M USD)

$11.85B

Forward P/E

10.55

PEG

0.03

PRICE TO SALES

0.87

PRICE TO BOOK

6.32

EV / EBITDA

21.78

5-Year Average P/E

Free Cash Flow Yield

3.48%

DCF Value

$13.17

Graham Number

$15.82

Price to FCF

28.75

EV to FCF

33.14

Earnings Yield

1.88%

FCF Yield

3.48%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$1.15

Next Year EPS Growth Estimate

$5.79

Next Year Revenue Growth Estimate

$28.68B

Return on Equity (ROE)

12.71%

FREE CASH FLOW

Operating Margin

3.42%

Debt-to-Equity

1.52

Piotroski F-Score

8

Altman Z-Score

4.34

Return on Invested Capital (ROIC)

9.99%

Current Ratio

1.74

Quick Ratio

1.38

Net Debt to EBITDA

2.89

Interest Coverage

3.02

Gross Profit margin

12.18%

FCF PER SHARE

$2.01

REVENUE PER SHARE

$66.66

Analyze BTSG on TradingView

Gainseekers Quantitative Analysis

Summary

BTSG BrightSpring Health Services, Inc. appears to be a perplexing case of market mispricing. Despite a snapshot price that traded significantly above its DCF Value and Graham Number, the Forward P/E ratio suggests a potential growth story that the market might be underestimating. The Altman Z-score of 4.18 indicates financial stability, while the Earnings Yield of 2.76% raises questions about its current valuation appeal. The market cap is substantial, yet the stock’s valuation metrics paint a picture of a company priced for future perfection rather than present value.

AI Exposure / Tech Reliance

In the rapidly evolving healthcare information services sector, BTSG is strategically positioned to leverage AI and modern tech advancements. The industry’s inherent need for data analytics and streamlined information flow aligns well with AI integration, potentially enhancing operational efficiencies. This adaptability could serve as a buffer against technological disruptions, ensuring sustained relevance.

The Bull Case

For the discerning GARP investor, BTSG offers compelling reasons to buy. The robust ROIC of 9.99% and a high Piotroski F-Score of 8 signal strong operational efficiency and financial health. Despite a modest operating margin of 3.42%, the company’s ability to generate free cash flow, albeit at a low yield, suggests underlying pricing power. These metrics collectively indicate a business capable of capitalizing on growth opportunities while maintaining fiscal discipline.

The Bear Case

However, the bear case for BTSG cannot be ignored. The stock's Price/Book ratio of 5.67 and Price/Sales ratio of 0.78 suggest a valuation that may be stretched relative to its book value and sales. With the stock trading near its 52-week high, technical overextension is a concern. Additionally, the EV to EBITDA of 19.84 raises red flags about the company's ability to generate cash relative to its enterprise value, hinting at potential overvaluation.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$58.50

Institutional Ownership %

1-Year Beta

1.72

Insider Buying % (6 Mo)

Distance to 52-Week High

1.65%

Distance to 52-Week Low

68.89%

EARNINGS SURPRISE %

34.48%

50-DAY SMA

$49.38

200-DAY SMA

$37.67

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.